Comparative effectiveness research for sarcoma

Research output: Contribution to journalArticle

Abstract

Modern multidisciplinary management of sarcoma represents several opportunities for comparative effectiveness research. Focusing on the outcomes of survival, quality of life and cost-effectiveness of care, the current state of the art is summarized. Specialized/regional care for sarcoma and the utility of tumor boards or multispecialty discussion is discussed. Issues related to treatment efficacy and sequencing in relation to chemotherapy, radiation, and surgery as well as margin reporting and surveillance are also discussed. Finally, future avenues of comparative effectiveness research for sarcoma are highlighted throughout the chapter.

Original languageEnglish (US)
Pages (from-to)51-65
Number of pages15
JournalCancer Treatment and Research
Volume164
DOIs
StatePublished - 2015

Fingerprint

Comparative Effectiveness Research
Sarcoma
Cost-Benefit Analysis
Quality of Life
Radiation
Drug Therapy
Neoplasms

Keywords

  • Comparative effectiveness Research
  • Extremity sarcoma
  • Retroperitoneal sarcoma

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Medicine(all)

Cite this

Comparative effectiveness research for sarcoma. / Wasif, Nabil.

In: Cancer Treatment and Research, Vol. 164, 2015, p. 51-65.

Research output: Contribution to journalArticle

@article{85dc7e1f8edd4eabbc431054cfb6a533,
title = "Comparative effectiveness research for sarcoma",
abstract = "Modern multidisciplinary management of sarcoma represents several opportunities for comparative effectiveness research. Focusing on the outcomes of survival, quality of life and cost-effectiveness of care, the current state of the art is summarized. Specialized/regional care for sarcoma and the utility of tumor boards or multispecialty discussion is discussed. Issues related to treatment efficacy and sequencing in relation to chemotherapy, radiation, and surgery as well as margin reporting and surveillance are also discussed. Finally, future avenues of comparative effectiveness research for sarcoma are highlighted throughout the chapter.",
keywords = "Comparative effectiveness Research, Extremity sarcoma, Retroperitoneal sarcoma",
author = "Nabil Wasif",
year = "2015",
doi = "10.1007/978-3-319-12553-4_4",
language = "English (US)",
volume = "164",
pages = "51--65",
journal = "Cancer Treatment and Research",
issn = "0927-3042",
publisher = "Springer Netherlands",

}

TY - JOUR

T1 - Comparative effectiveness research for sarcoma

AU - Wasif, Nabil

PY - 2015

Y1 - 2015

N2 - Modern multidisciplinary management of sarcoma represents several opportunities for comparative effectiveness research. Focusing on the outcomes of survival, quality of life and cost-effectiveness of care, the current state of the art is summarized. Specialized/regional care for sarcoma and the utility of tumor boards or multispecialty discussion is discussed. Issues related to treatment efficacy and sequencing in relation to chemotherapy, radiation, and surgery as well as margin reporting and surveillance are also discussed. Finally, future avenues of comparative effectiveness research for sarcoma are highlighted throughout the chapter.

AB - Modern multidisciplinary management of sarcoma represents several opportunities for comparative effectiveness research. Focusing on the outcomes of survival, quality of life and cost-effectiveness of care, the current state of the art is summarized. Specialized/regional care for sarcoma and the utility of tumor boards or multispecialty discussion is discussed. Issues related to treatment efficacy and sequencing in relation to chemotherapy, radiation, and surgery as well as margin reporting and surveillance are also discussed. Finally, future avenues of comparative effectiveness research for sarcoma are highlighted throughout the chapter.

KW - Comparative effectiveness Research

KW - Extremity sarcoma

KW - Retroperitoneal sarcoma

UR - http://www.scopus.com/inward/record.url?scp=84923344660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923344660&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-12553-4_4

DO - 10.1007/978-3-319-12553-4_4

M3 - Article

C2 - 25677018

AN - SCOPUS:84923344660

VL - 164

SP - 51

EP - 65

JO - Cancer Treatment and Research

JF - Cancer Treatment and Research

SN - 0927-3042

ER -